R

Rainier Acquisition Corp

RNAQURecent IPO

Rainier Acquisition Corp · Nasdaq · Research source · 424B4 · 2026-08-27 · Latest filing · 10-Q · 2026-11-16 SEC ↗

Report source
Research source · 424B4 · 2026-08-27
SummaryBASIC RESEARCHReport source · 424B4

IPO research

The prospectus describes a $75 million SPAC IPO of 7.5 million units at $10.00 per unit, with a 24-month business-combination window and no selected target.

Full source-backed summary

Rainier Acquisition Corp is a newly offered Cayman Islands SPAC seeking $75.0 million before any over-allotment. It has no identified target, and the principal investor considerations are redemption/liquidation uncertainty, sponsor dilution, conflicts of interest and limited operating history.

The prospectus describes a $75 million SPAC IPO of 7.5 million units at $10.00 per unit, with a 24-month business-combination window and no selected target.

Ownership and votingAwaiting verified holder data— economic · — voting
Next disclosed checkpointExpected offering delivery and closing are on or about August 28, 2026; separate trading is expected on the 52nd day after the prospectus date unless permitted earlier.424B4 · 2026-08-27
Business and development direction

Rainier Acquisition Corp

Current business
Future development
DECISION DRIVERS

Key risks

Risk 1

Investors do not receive Rule 419 blank-check protections.

Risk 2

Large redemptions may prevent completion of the most desirable business combination or an optimized capital structure.

Risk 3

The sponsor and management may have fiduciary or contractual obligations to other entities and may face conflicts in allocating opportunities.

Next checkExpected offering delivery and closing are on or about August 28, 2026; separate trading is expected on the 52nd day after the prospectus date unless permitted earlier.
Latest filing2026-11-16
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Offering qualitySome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
BOOKRUNNERS / LEAD UNDERWRITERSUnderwriters named in the prospectus
CONFIRMED
#InstitutionUnderwriting allocationRatio · calculatedUnits
1Chardan Capital Markets LLC100.00%7,500,000 Units

Ratio = institution commitment ÷ complete source-table total (7,500,000 Units) × 100.

Source and calculation

Allocation ratios are calculated from each reported commitment and the complete total in the same source table; they are not ownership or fee percentages.

Underwriting purchase commitments as disclosed; units; no conversion to constituent securities; source column: Number of Units

Number of Units

SEC table 404 row 5; source 2042527:2046357; SHA256 49e1de539634bdd1d2ce6e27ce6a09972ef07b9422695666b397bd417c601fd0

Chardan Capital Markets LLC: 7500000 / 7500000 × 100

Source · 424B4 ↗

Underwriting terms

Underwriting terms
MeasureReported valueUnit
Underwriting discount per unit$0.35$ / security
Total underwriting discount$2,625,000$
Source and calculation

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.

Underwriting discount per unit

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities

SEC table 2 row 5; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.

Total underwriting discount

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities

SEC table 2 row 5; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗

IPO CAPITAL QUALITY

Offering price per unit $ / security$10
Gross offering amount $$75,000,000
Underwriting discount per unit $ / security$0.35
Total underwriting discount $$2,625,000
Basis and evidence

424B4 · 2026-08-27

The prospectus describes a $75 million SPAC IPO of 7.5 million units at $10.00 per unit, with a 24-month business-combination window and no selected target.

Offering structure

Offering terms
MeasureReported valueUnit
Offering price per unit$10$ / security
Gross offering amount$75,000,000$
Source and calculation

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.

Offering price per unit

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities

SEC table 2 row 4; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.

Gross offering amount

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities

SEC table 2 row 4; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗
Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Use of proceedsSource-linked structured inputs are not yet available. Open filing ↗

Dilution and valuation

IPO price$10 / unitPrice status unverified
Basic post-offer—
Equity value—

Reported figures remain on their stated basis. Exact compatible price and whole-issuer post-offer inputs are required for calculations.

Dilution and valuation
CalculationSharesValueReference
Pre-offer shares (as disclosed)2,156,250—
Reported sourcePre-offersharesBasis and evidence 1 ↗
Pre-offer Units — as disclosed—0
Reported sourceunitsBasis and evidence 2 ↗
Post-offer Units — as disclosed—7,694,375
Reported sourceunitsBasis and evidence 3 ↗
Pre-offer Ordinary shares — as disclosed2,156,250—
Reported sourcePre-offersharesBasis and evidence 4 ↗
Post-offer Ordinary shares — as disclosed9,569,375—
Reported sourcePost-offersharesBasis and evidence 5 ↗
Pre-offer Ordinary shares — as disclosed2,156,250—
Reported sourcePre-offersharesBasis and evidence 6 ↗
Post-offer warrants — as disclosed—1,923,593 warrants
Reported sourcetextBasis and evidence 7 ↗
Offering price per unit—$10
Reported sourcePrice status unverified$/securityBasis and evidence 8 ↗
Gross offering amount—$75,000,000
Reported source$Basis and evidence 8 ↗
Basis and evidence ↗
Basis and evidence 1

Ordinary shares outstanding before the offering as disclosed; separately stated offering-related forfeiture remains a distinct stage

Figures retain their stated source scenario and conditions.

SEC table 210 row 23; source 1009307:1210928; SHA256 ac264e29a1f68ec3bd3712bc0835130c9ae8139f3f65a1e83a0d1aa59b050242 ↗

Basis and evidence 2

Prospectus share summary; Number outstanding before this offering; 0; selected security: Units; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 49 row 11 columns 3; share summary; label column 1; header cells 9:1; source 270552:283049; SHA256 b1e847fd5d4ca07ed13e3ff292f7819ec8e6f49474b619145e7c6545184319c2 ↗

Basis and evidence 3

Prospectus share summary; Number outstanding after this offering; 7,694,375(1); selected security: Units; selected scenario: as disclosed; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 49 row 13 columns 3; share summary; label column 1; source 270552:283049; SHA256 b1e847fd5d4ca07ed13e3ff292f7819ec8e6f49474b619145e7c6545184319c2 ↗

Basis and evidence 4

Prospectus share summary; Number outstanding before this offering; 2,156,250(2)(3); selected security: Ordinary shares; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 50 row 4 columns 3; share summary; label column 1; header cells 2:1; source 284646:300734; SHA256 ab27d45a0bb930bcde4cb0aef71ade0900a1d34bc7ad69b1ec7c361542a2eca1 ↗

Basis and evidence 5

Prospectus share summary; Number outstanding after this offering; 9,569,375(1)(2)(4); selected security: Ordinary shares; selected scenario: as disclosed; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 50 row 6 columns 3; share summary; label column 1; source 284646:300734; SHA256 ab27d45a0bb930bcde4cb0aef71ade0900a1d34bc7ad69b1ec7c361542a2eca1 ↗

Basis and evidence 6

Prospectus share summary; Ordinary shares outstanding prior to this offering; identical printed pre-offer counts across columns 4,7,10,13,16,19,22,25,28,31; 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250 2,156,250; selected security: Ordinary shares; selected scenario: as disclosed; separately stated forfeiture or conversion is not applied to this printed pre-offer count; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 210 row 23 columns 4,7,10,13,16,19,22,25,28,31; share summary; label column 1; source 1009307:1210928; SHA256 ac264e29a1f68ec3bd3712bc0835130c9ae8139f3f65a1e83a0d1aa59b050242 ↗

Basis and evidence 7

Prospectus share summary; Number of warrants to be outstanding after this offering and the sale of private placement warrants; 1,923,593(1); selected security: warrants; selected scenario: as disclosed; no inferred sum, conversion or equity value

Figures retain their stated source scenario and conditions.

SEC table 50 row 12 columns 3; share summary; label column 1; source 284646:300734; SHA256 ab27d45a0bb930bcde4cb0aef71ade0900a1d34bc7ad69b1ec7c361542a2eca1 ↗

Basis and evidence 8

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities

Prospectus cover; per-unit and total columns as disclosed; no conversion to constituent securities Figures retain their stated source scenario and conditions.

Exact input · Offering price per unit: $10

SEC table 2 row 4; source 96696:106439; SHA256 a87567b422c167c748bbf85cbc2f0b0943ceee882a3266830a55ac5cc42755e1 ↗

Share-count comparison

Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.

Source ↗
SCENARIO · NOT A FORECAST

IPO valuation scenario simulator

Source inputs required

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Source ↗
Implied equity value—Price × post-offer shares
Post-offer shares—Share count, not tradable float
Existing-holder ownership reduction—Assumes new shares only; secondary sales do not increase shares.
Source and calculation ↗
Security and offer price

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Base post-offer shares

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Equity value

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Share-count change

Compatible whole-issuer pre-offer and post-offer share counts are missing; holder, class-only or offered-share counts cannot substitute for them.

Alternative scenarios

Source facts remain available under their explicit security, scenario, period and precision; required compatible inputs are incomplete.

Sensitivity

Compatible source-bound inputs are not available; absence is not a non-disclosure finding.

Source and calculation

The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.

Sources and calculation notes

Read this report’s SEC filing ↗

Calculation inputs
ViewSource basis
Ownership across stagesSome sourced inputs are available; a compatible set is needed for this view. Open filing ↗
As of
2026-08-27
!Ravenna 7 LLC is the sponsor. Founder shares are controlled through Jonas Grossman and carry special pre-business-combination director appointment and removal rights. The sponsor and management waive specified redemption and liquidation rights on insider securities.View source ↗
Relationship filters
Show
ownership / voting rights
share structure
Select for details · Rainier Acquisition Corp
Founder / personFund / entityPublic floatShare classEvery relationship is dated and linked to its supporting SEC filing. Percentages marked * are filing-based estimates.

Holdings and voting rights

Holder groups may overlap; these rows are not an additive ownership partition.

Holdings and voting rights
Holder / measureSharesOwnershipVoting rightsReference
our sponsorOwnership as disclosed—approximately 20%Beneficial—
Source statement; approximately ; source predicate: will own; primary source clause; source condition: assuming it does not purchase any units in this offering); source scope: of our issued and outstanding ordinary shares (assuming it does not purchase any units in this offering); not an additive ownership partitionDisclosedEvidence
Our sponsor, directors and director nomineesOwnership as disclosed—20%Beneficial—
Source statement; as stated; source predicate: will own; primary source clause; full source conditions retained; source scope: of our outstanding ordinary shares immediately following the completion of this offering; not an additive ownership partitionDisclosedEvidence
our sponsor, directors and director nomineesOwnership as disclosed—20%Beneficial—
Source statement; as stated; source predicate: will own; primary source clause; full source conditions retained; source scope: of our issued and outstanding shares after this offering and the expiration of the underwriters’ option to purchase additional units, including 1,875,000 Class B ordinary shares and 194,375 private p; not an additive ownership partitionDisclosedEvidence
Class A ordinary shares——1 votes per shareVotes per share
Literal class voting rights; not a holder voting percentageDisclosedEvidence
Class B ordinary shares——1 votes per shareVotes per share
Literal class voting rights; not a holder voting percentageDisclosedEvidence
Class A ordinary shares——1 votes per shareVotes per share
Literal class voting rights; not a holder voting percentageDisclosedEvidence
Ravenna 7 LLC (our sponsor)Beneficial shares1,944,375——
Number of; Shares; Beneficially; Owned(2)DisclosedEvidence
Gbola Amusa, M.D., CFABeneficial shares25,000——
Number of; Shares; Beneficially; Owned(2)DisclosedEvidence
Isaac Manke, Ph.D.Beneficial shares25,000——
Number of; Shares; Beneficially; Owned(2)DisclosedEvidence
Jonas GrossmanBeneficial shares1,969,375——
Number of; Shares; Beneficially; Owned(2)DisclosedEvidence
Andrew Lam, PharmDBeneficial shares25,000——
Number of; Shares; Beneficially; Owned(2)DisclosedEvidence
Chidozie UgwumbaBeneficial shares25,000——
Number of; Shares; Beneficially; Owned(2)DisclosedEvidence
All officers, directors and director nominees as a group (6 individuals)Beneficial shares2,069,375——
Number of; Shares; Beneficially; Owned(2)DisclosedEvidence
Ravenna 7 LLC (our sponsor)Beneficial ownership—94%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; OfferingDisclosedEvidence
Ravenna 7 LLC (our sponsor)Beneficial ownership—20.3%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; OfferingDisclosedEvidence
Gbola Amusa, M.D., CFABeneficial ownership—1.2%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; OfferingDisclosedEvidence
Isaac Manke, Ph.D.Beneficial ownership—1.2%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; OfferingDisclosedEvidence
Jonas GrossmanBeneficial ownership—95.2%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; OfferingDisclosedEvidence
Jonas GrossmanBeneficial ownership—20.6%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; OfferingDisclosedEvidence
Andrew Lam, PharmDBeneficial ownership—1.2%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; OfferingDisclosedEvidence
Chidozie UgwumbaBeneficial ownership—1.2%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; OfferingDisclosedEvidence
All officers, directors and director nominees as a group (6 individuals)Beneficial ownership—100%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; OfferingDisclosedEvidence
All officers, directors and director nominees as a group (6 individuals)Beneficial ownership—21.6%Beneficial—
Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; OfferingDisclosedEvidence
Source and calculation ↗
our sponsor · our sponsor — Ownership as disclosed · approximately 20%

Source statement; approximately ; source predicate: will own; primary source clause; source condition: assuming it does not purchase any units in this offering); source scope: of our issued and outstanding ordinary shares (assuming it does not purchase any units in this offering); not an additive ownership partition

Upon closing of this offering, our sponsor will own, on an as-converted basis, approximately 20% of our issued and outstanding ordinary shares (assuming it does not purchase any units in this offering). Accordingly, it may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you do not support, including amendments to our amended and restated memorandum and articles of association. If our sponsor purchases any units in this offering or if our sponsor purchases any additional

0001104659-26-102498 · SEC ownership paragraph; source 818822:819506; SHA256 39a38ab89a675f0dd7139ed79b657bd87474e3465f6442a783633111a1de6dee ↗

Our sponsor, directors and director nominees · Our sponsor, directors and director nominees — Ownership as disclosed · 20%

Source statement; as stated; source predicate: will own; primary source clause; full source conditions retained; source scope: of our outstanding ordinary shares immediately following the completion of this offering; not an additive ownership partition

Our sponsor, directors and director nominees will own, on an as-converted basis, 20% of our outstanding ordinary shares immediately following the completion of this offering. Our sponsor and members of our management team also may from time to time purchase Class A ordinary shares prior to our initial business combination. Our amended and restated memorandum and articles of association will provide that, if we seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law and our amended and restated memorandum and articles of association. As a result, in addition to our sponsor’s founder shares and private placement shares, we would need 2,715,313, or 28.4% (assuming all issued and outstanding shares are voted and the over-allotment option is not exercised), or no public shareholder votes would be required (assuming only the minimum number of shares representing a quorum are voted and the over-allotment option is not exercised) for an ordinary resolution, or 4,310,209, or 45.0% (assuming all issued and outstanding shares are voted and the over-allotment option is not exercised), and no public shareholder votes would be required (assuming only the minimum number of shares representing a quorum are voted and the over-allotment option is not exercised) for a special resolution, if required, of the 7,500,000 public shares sold in this offering to be voted in favor of an initial business combination in order to have our initial business combination approved. Assuming that only the holders of one-third of our issued and outstanding ordinary shares, representing a quorum under our amended and restated memorandum and articles of association, vote their ordinary shares at a general meeting of the company, we will not need any public shares in addition to our founder shares to be voted in favor of an ordinary resolution approving an initial business combination in order to approve an initial business combination, unless such initial business combination is structured as a statutory merger or consolidation under Cayman Islands law requiring shareholders’ approval by way of a special resolution. Accordingly, if we seek shareholder approval of our initial business combination, the agreement by our sponsor and each member of our management team to vote in favor of our initial business combination will increase the likelihood that we will receive the requisite shareholder approval for such initial business combination.

0001104659-26-102498 · SEC ownership paragraph; source 535765:538496; SHA256 be291ebb7788def9d7311dff8924965aeacb336815d269189403000f9ffa126d ↗

our sponsor, directors and director nominees · our sponsor, directors and director nominees — Ownership as disclosed · 20%

Source statement; as stated; source predicate: will own; primary source clause; full source conditions retained; source scope: of our issued and outstanding shares after this offering and the expiration of the underwriters’ option to purchase additional units, including 1,875,000 Class B ordinary shares and 194,375 private p; not an additive ownership partition

Prior to the date of this prospectus, there were 2,156,250 Class B ordinary shares issued and outstanding, all of which were held of record by our sponsor, directors and director nominees, including 2,031,250 founder shares held of record by our sponsor and 25,000 founder shares held of record by each of our directors and director nominees, so that, assuming no exercise of the underwriters’ option to purchase additional units (resulting in the forfeiture by our sponsor of 281,250 Class B ordinary shares) and assuming that our sponsor purchases 194,375 private placement units concurrently with the completion of this offering, our sponsor, directors and director nominees will own an aggregate of 20% of our issued and outstanding shares after this offering and the expiration of the underwriters’ option to purchase additional units, including 1,875,000 Class B ordinary shares and 194,375 private placement shares. Upon the closing of this offering, 9,569,375 of our ordinary shares will be outstanding (assuming no exercise of the underwriters’ over-allotment option) including:

0001104659-26-102498 · SEC ownership paragraph; source 1764877:1766152; SHA256 7b520707d73cf905cd91cb4a8842c45ed5fdfe98a9f842338e44e8996a1b2e14 ↗

Class A ordinary shares · Class A ordinary shares · 1 votes per share

Literal class voting rights; not a holder voting percentage

The Company is authorized to issue 100,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of December 31, 2025 and December 31, 2024, there were no shares issued or outstanding.

0001104659-26-102498 · SEC ownership paragraph; source 2390501:2390935; SHA256 0ef4910ecc6aa762d2b88bc5a5aec59d0ec0f5eb213c2ea1392f55b519f26560 ↗

Class B ordinary shares · Class B ordinary shares · 1 votes per share

Literal class voting rights; not a holder voting percentage

The Company is authorized to issue 10,000,000 Class B ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class B ordinary shares are entitled to one vote for each share.

0001104659-26-102498 · SEC ownership paragraph; source 2391097:2391429; SHA256 b8aa5b3fe261c53b4b14fac57b0f05ae984835a5dc8ff69bdbb9d06420f52df6 ↗

Class A ordinary shares · Class A ordinary shares · 1 votes per share

Literal class voting rights; not a holder voting percentage

The Company is authorized to issue 100,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2026 and December 31, 2025 there were no shares issued or outstanding.

0001104659-26-102498 · SEC ownership paragraph; source 2667843:2668252; SHA256 55e6311235236e0ae13888426f4691e6283483ad99f94db53bd0f7fff0829473 ↗

Ravenna 7 LLC (our sponsor) · Ravenna 7 LLC (our sponsor) — Beneficial shares · 1,944,375

Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition

Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Ravenna 7 LLC (our sponsor)

0001104659-26-102498 · SEC table 322 row 10 columns 3; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 6:3,7:3,8:3,9:3 ↗

Gbola Amusa, M.D., CFA · Gbola Amusa, M.D., CFA — Beneficial shares · 25,000

Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition

Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Gbola Amusa, M.D., CFA

0001104659-26-102498 · SEC table 322 row 11 columns 3; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 6:3,7:3,8:3,9:3 ↗

Isaac Manke, Ph.D. · Isaac Manke, Ph.D. — Beneficial shares · 25,000

Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition

Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Isaac Manke, Ph.D.

0001104659-26-102498 · SEC table 322 row 13 columns 3; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 6:3,7:3,8:3,9:3 ↗

Jonas Grossman · Jonas Grossman — Beneficial shares · 1,969,375

Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition

Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Jonas Grossman

0001104659-26-102498 · SEC table 322 row 14 columns 3; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 6:3,7:3,8:3,9:3 ↗

Andrew Lam, PharmD · Andrew Lam, PharmD — Beneficial shares · 25,000

Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition

Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Andrew Lam, PharmD

0001104659-26-102498 · SEC table 322 row 15 columns 3; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 6:3,7:3,8:3,9:3 ↗

Chidozie Ugwumba · Chidozie Ugwumba — Beneficial shares · 25,000

Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition

Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: Chidozie Ugwumba

0001104659-26-102498 · SEC table 322 row 16 columns 3; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 6:3,7:3,8:3,9:3 ↗

All officers, directors and director nominees as a group (6 individuals) · All officers, directors and director nominees as a group (6 individuals) — Beneficial shares · 2,069,375

Exact source ownership column: Number of; Shares; Beneficially; Owned(2); holders may overlap; not an additive partition

Raw source column: Number of; Shares; Beneficially; Owned(2); source holder: All officers, directors and director nominees as a group (6 individuals)

0001104659-26-102498 · SEC table 322 row 17 columns 3; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 6:3,7:3,8:3,9:3 ↗

Ravenna 7 LLC (our sponsor) · Ravenna 7 LLC (our sponsor) — Beneficial ownership · 94%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Ravenna 7 LLC (our sponsor)

0001104659-26-102498 · SEC table 322 row 10 columns 5,6; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:5,9:5 ↗

Ravenna 7 LLC (our sponsor) · Ravenna 7 LLC (our sponsor) — Beneficial ownership · 20.3%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; source holder: Ravenna 7 LLC (our sponsor)

0001104659-26-102498 · SEC table 322 row 10 columns 7,8; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:7,9:7 ↗

Gbola Amusa, M.D., CFA · Gbola Amusa, M.D., CFA — Beneficial ownership · 1.2%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Gbola Amusa, M.D., CFA

0001104659-26-102498 · SEC table 322 row 11 columns 5,6; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:5,9:5 ↗

Isaac Manke, Ph.D. · Isaac Manke, Ph.D. — Beneficial ownership · 1.2%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Isaac Manke, Ph.D.

0001104659-26-102498 · SEC table 322 row 13 columns 5,6; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:5,9:5 ↗

Jonas Grossman · Jonas Grossman — Beneficial ownership · 95.2%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Jonas Grossman

0001104659-26-102498 · SEC table 322 row 14 columns 5,6; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:5,9:5 ↗

Jonas Grossman · Jonas Grossman — Beneficial ownership · 20.6%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; source holder: Jonas Grossman

0001104659-26-102498 · SEC table 322 row 14 columns 7,8; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:7,9:7 ↗

Andrew Lam, PharmD · Andrew Lam, PharmD — Beneficial ownership · 1.2%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Andrew Lam, PharmD

0001104659-26-102498 · SEC table 322 row 15 columns 5,6; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:5,9:5 ↗

Chidozie Ugwumba · Chidozie Ugwumba — Beneficial ownership · 1.2%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: Chidozie Ugwumba

0001104659-26-102498 · SEC table 322 row 16 columns 5,6; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:5,9:5 ↗

All officers, directors and director nominees as a group (6 individuals) · All officers, directors and director nominees as a group (6 individuals) — Beneficial ownership · 100%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; Before; Offering; source holder: All officers, directors and director nominees as a group (6 individuals)

0001104659-26-102498 · SEC table 322 row 17 columns 5,6; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:5,9:5 ↗

All officers, directors and director nominees as a group (6 individuals) · All officers, directors and director nominees as a group (6 individuals) — Beneficial ownership · 21.6%

Exact source ownership column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; holders may overlap; not an additive partition

Raw source column: Approximate Percentage; of Issued and Outstanding; Ordinary Shares; After; Offering; source holder: All officers, directors and director nominees as a group (6 individuals)

0001104659-26-102498 · SEC table 322 row 17 columns 7,8; source 1703109:1734669; SHA256 09371c6ba0de643bcd641bcbbc0d7d1b30c72d4b97519e7d8d86e8d4d15ee7bf; ownership header cells 3:5,4:5,5:5,8:7,9:7 ↗

Economic ownership

A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.

Share supply

Source lock-up conditions

Source lock-up conditions
MeasureReported value
We, our sponsor and our officers and directorsAfter date of this prospectus · Source conditions apply180 days
the private placement warrantsAfter completion of our initial business combination · Source conditions apply30 days
The private placement unitsAfter completion of our initial business combination · Source conditions apply30 days
private placement warrantsAfter completion of our initial business combination · Source conditions apply30 days
private placement unitsAfter completion of our initial business combination · Source conditions apply30 days
the private placement unitsAfter date of commencement of sales of the offering · Source conditions apply180 days
The private placement unitsAfter completion of our initial business combination · Source conditions apply30 days
the founder sharesAfter date of this prospectus · Source conditions apply180 days
the private placement unitsAfter completion of our initial business combination · Source conditions apply30 days
the private placement warrantsAfter completion of our initial business combination · Source conditions apply30 days
the private placement warrantsAfter completion of our initial business combination · Source conditions apply30 days
Source and calculation
We, our sponsor and our officers and directors

We, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of Chardan, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, units, warrants or ordinary shares; provided, however, that we may (1) issue and sell the private placement units, (2) issue and sell the additional units to cover our underwriters’ over-allotment option (if any), (3) register with the SEC pursuant to an, agreement to be

SEC lock-up paragraph; source 2073798:2074738; SHA256 def348ff7ba403343fafc5cde38397a99df9788b9584d4f829f43e8bbff7afd5 ↗
the private placement warrants

The private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders, except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”

SEC lock-up paragraph; source 348451:349367; SHA256 05e6986e15e9020e2428e8c7e397f110e4f9a70fac12c8763896af857b5c6b80 ↗
The private placement units

The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”

SEC lock-up paragraph; source 1740744:1744693; SHA256 b0f4e19c455a7f168ae582a6009de94ce6586713fd0320f577fd85f6240fc92e ↗
private placement warrants

Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination, unless approved by our public shareholders.

SEC lock-up paragraph; source 1747744:1748876; SHA256 07b6cbca35d3008d8e555878bf5042bceb4bf7c8ca9cd904fc329c131f956cf4 ↗
private placement units

The private placement units are identical to the public units issued in this offering, except that the private warrants contained in the private placement units will be non-redeemable and may be exercised on a cashless basis, but in each case only if they are held by the sponsor, subject to certain limited exceptions. The private placement units, other than private placement units issued upon conversion of working capital loans, and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders.

SEC lock-up paragraph; source 1787924:1788687; SHA256 b4ba097cdd8e6e37fcb19ecf2340d0be4a468fe9e7983dbd306d0da995ebfe4d ↗
the private placement units

Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.

SEC lock-up paragraph; source 1837667:1840091; SHA256 8acb5d1bedac4dde8dcf37e1ec02d55b32afc26ad19e7510571f6a496161ca25 ↗
The private placement units

The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell the founder shares for a period ending on the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information, also see “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”

SEC lock-up paragraph; source 2076438:2080252; SHA256 87ed8c98f057f0c4487e82a52ee6c5fbeed3bcd5d6ba920ed2cd8c0c350e086b ↗
the founder shares

Our letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.

SEC lock-up paragraph; source 806691:807852; SHA256 bba8d10b503d05943cd7b766e3caae779b4ae4186705b6a062cf50bd2df87525 ↗
the private placement units

assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement units (other than those issued upon conversion of working capital loans) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Because each of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.

SEC lock-up paragraph; source 1686996:1688453; SHA256 5a573f59fbc57f28b556cbc53aace339190a6b79a195e6b83cf4f7d765c928fa ↗
the private placement warrants

Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.

SEC lock-up paragraph; source 1837667:1840091; SHA256 8acb5d1bedac4dde8dcf37e1ec02d55b32afc26ad19e7510571f6a496161ca25 ↗
the private placement warrants

Except as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Our sponsor, officers and directors have also agreed not to transfer, assign or sell private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. These transfer restrictions terminate upon the completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up.

SEC lock-up paragraph; source 1941422:1943288; SHA256 b3ca2e7d20557f67f4f638e52368f5b860604f353389115c9c9773e6e24c18ac ↗

Source lock-up conditions

Literal day restriction; anchor not separately resolved; full conditions and exceptions remain in the source paragraph

Source lock-up conditions
MeasureReported value
the private placement units30 days
the private placement units30 days
the private placement units30 days
the private placement units30 days
the private placement units30 days
Source and calculation
the private placement units

Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Any such payments will be made either (i) prior to our initial business combination using proceeds of this offering and the sale of the private placement units held outside the trust account or from loans made to us by our sponsor or an affiliate of our sponsor or certain of our officers and directors or (ii) in connection with or after the consummation of our initial business combination.

SEC lock-up paragraph; source 431997:433223; SHA256 f17717e16e180e32adae27d97fba86b88fe77f4649a82eec5122e33ca5bdb12c ↗
the private placement units

the formation promissory note and the grid promissory note to be used for, among other things, working capital, transaction expenses and other expenses related to this offering and our operations. To date, we have borrowed $25,000 and $78,898.08 under the formation promissory note and grid promissory note, respectively. For a more complete description of the terms of the promissory notes, see “Certain Relationships and Related Party Transactions.” If we are required to seek additional capital, we would need to borrow funds from our sponsor, its affiliates, members of our management team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor their affiliates is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or from funds released to us upon the completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.

SEC lock-up paragraph; source 609867:612380; SHA256 a896a7c63249e603a29953ce24fe2b572fbf8879fc109120a42e11cb99e847c4 ↗
the private placement units

In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

SEC lock-up paragraph; source 995771:997489; SHA256 94371c8d080e0dc5b857161d7e414d2343a39552f437aea0000b8536c7fc2987 ↗
the private placement units

In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

SEC lock-up paragraph; source 1753442:1754994; SHA256 409e936bd12c8e0e816d2c4166684d599725098e81e61c266eb3e84cf23a3091 ↗
the private placement units

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination.

SEC lock-up paragraph; source 1843028:1843804; SHA256 0951346a60d9107e1d62e2bad7bf2ed934cf426ee4a1ebfb083f424613e9ce49 ↗

Source lock-up conditions

Literal month restriction; after completion of our initial business combination; full conditions and exceptions remain in the source paragraph

Source lock-up conditions
MeasureReported value
private placement unitsAfter completion of our initial business combination · Source conditions apply6 months
Source and calculation
private placement units

Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until (i) with respect to 50% of the private placement units, for a period ending the earlier of (A) six months after the completion of our initial business combination and (B) subsequent to our initial business combination, if the closing price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination and (ii) with respect to the other 50% of private placement units, until six months after the completion of our initial business combination, unless approved by our public shareholders

SEC lock-up paragraph; source 1310765:1312522; SHA256 eb6555437cfd8ff0b9a82dfc54656be526f9cdc296597458d1f38735a1e5464a ↗

Conditional lock-up timeline

Conditional lock-up timeline

Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.

date of this prospectus

  1. We, our sponsor and our officers and directorsWe, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of Chardan, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, units, warrants or ordinary shares; provided, however, that we may (1) issue and sell the private placement units, (2) issue and sell the additional units to cover our underwriters’ over-allotment option (if any), (3) register with the SEC pursuant to an, agreement to be
  2. the founder sharesOur letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.
Holder / event
Holder / eventTerm / dateConditions
We, our sponsor and our officers and directors180 daysWe, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of Chardan, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, units, warrants or ordinary shares; provided, however, that we may (1) issue and sell the private placement units, (2) issue and sell the additional units to cover our underwriters’ over-allotment option (if any), (3) register with the SEC pursuant to an, agreement to be
the founder shares180 daysOur letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.

completion of our initial business combination

  1. the private placement warrantsThe private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders, except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
  2. The private placement unitsThe founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
  3. private placement warrantsOur sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
  4. private placement unitsThe private placement units are identical to the public units issued in this offering, except that the private warrants contained in the private placement units will be non-redeemable and may be exercised on a cashless basis, but in each case only if they are held by the sponsor, subject to certain limited exceptions. The private placement units, other than private placement units issued upon conversion of working capital loans, and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
  5. The private placement unitsThe founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell the founder shares for a period ending on the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information, also see “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
  6. the private placement unitsassign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement units (other than those issued upon conversion of working capital loans) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Because each of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
  7. the private placement warrantsExcept as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
  8. the private placement warrantsExcept as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Our sponsor, officers and directors have also agreed not to transfer, assign or sell private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. These transfer restrictions terminate upon the completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up.
Holder / event
Holder / eventTerm / dateConditions
the private placement warrants30 daysThe private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders, except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
The private placement units30 daysThe founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
private placement warrants30 daysOur sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
private placement units30 daysThe private placement units are identical to the public units issued in this offering, except that the private warrants contained in the private placement units will be non-redeemable and may be exercised on a cashless basis, but in each case only if they are held by the sponsor, subject to certain limited exceptions. The private placement units, other than private placement units issued upon conversion of working capital loans, and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders.
The private placement units30 daysThe founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell the founder shares for a period ending on the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information, also see “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”
the private placement units30 daysassign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement units (other than those issued upon conversion of working capital loans) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Because each of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.
the private placement warrants30 daysExcept as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
the private placement warrants30 daysExcept as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Our sponsor, officers and directors have also agreed not to transfer, assign or sell private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. These transfer restrictions terminate upon the completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up.

date of commencement of sales of the offering

  1. the private placement unitsExcept as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.
Holder / event
Holder / eventTerm / dateConditions
the private placement units180 daysExcept as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.

Milestones and unconfirmed releases

Holder / event
Holder / eventTerm / dateConditions
the private placement units30 daysRepayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Any such payments will be made either (i) prior to our initial business combination using proceeds of this offering and the sale of the private placement units held outside the trust account or from loans made to us by our sponsor or an affiliate of our sponsor or certain of our officers and directors or (ii) in connection with or after the consummation of our initial business combination.
the private placement units30 daysthe formation promissory note and the grid promissory note to be used for, among other things, working capital, transaction expenses and other expenses related to this offering and our operations. To date, we have borrowed $25,000 and $78,898.08 under the formation promissory note and grid promissory note, respectively. For a more complete description of the terms of the promissory notes, see “Certain Relationships and Related Party Transactions.” If we are required to seek additional capital, we would need to borrow funds from our sponsor, its affiliates, members of our management team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor their affiliates is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or from funds released to us upon the completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.
the private placement units30 daysIn addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
the private placement units30 daysIn addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.
the private placement units30 daysIn order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination.

completion of our initial business combination

  1. private placement unitsOur sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until (i) with respect to 50% of the private placement units, for a period ending the earlier of (A) six months after the completion of our initial business combination and (B) subsequent to our initial business combination, if the closing price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination and (ii) with respect to the other 50% of private placement units, until six months after the completion of our initial business combination, unless approved by our public shareholders
Holder / event
Holder / eventTerm / dateConditions
private placement units6 monthsOur sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until (i) with respect to 50% of the private placement units, for a period ending the earlier of (A) six months after the completion of our initial business combination and (B) subsequent to our initial business combination, if the closing price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination and (ii) with respect to the other 50% of private placement units, until six months after the completion of our initial business combination, unless approved by our public shareholders
Basis and evidence
We, our sponsor and our officers and directors

We, our sponsor and our officers and directors have agreed that, for a period of 180 days from the date of this prospectus, we and they will not, without the prior written consent of Chardan, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, units, warrants or ordinary shares; provided, however, that we may (1) issue and sell the private placement units, (2) issue and sell the additional units to cover our underwriters’ over-allotment option (if any), (3) register with the SEC pursuant to an, agreement to be

SEC lock-up paragraph; source 2073798:2074738; SHA256 def348ff7ba403343fafc5cde38397a99df9788b9584d4f829f43e8bbff7afd5 ↗
the private placement warrants

The private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders, except as described herein under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”

SEC lock-up paragraph; source 348451:349367; SHA256 05e6986e15e9020e2428e8c7e397f110e4f9a70fac12c8763896af857b5c6b80 ↗
The private placement units

The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”

SEC lock-up paragraph; source 1740744:1744693; SHA256 b0f4e19c455a7f168ae582a6009de94ce6586713fd0320f577fd85f6240fc92e ↗
private placement warrants

Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until 30 days after the completion of our initial business combination, unless approved by our public shareholders.

SEC lock-up paragraph; source 1747744:1748876; SHA256 07b6cbca35d3008d8e555878bf5042bceb4bf7c8ca9cd904fc329c131f956cf4 ↗
private placement units

The private placement units are identical to the public units issued in this offering, except that the private warrants contained in the private placement units will be non-redeemable and may be exercised on a cashless basis, but in each case only if they are held by the sponsor, subject to certain limited exceptions. The private placement units, other than private placement units issued upon conversion of working capital loans, and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders.

SEC lock-up paragraph; source 1787924:1788687; SHA256 b4ba097cdd8e6e37fcb19ecf2340d0be4a468fe9e7983dbd306d0da995ebfe4d ↗
the private placement units

Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.

SEC lock-up paragraph; source 1837667:1840091; SHA256 8acb5d1bedac4dde8dcf37e1ec02d55b32afc26ad19e7510571f6a496161ca25 ↗
The private placement units

The founder shares, private placement units and any Class A ordinary shares issued upon conversion or exercise thereof are each subject to transfer restrictions pursuant to lock-up provisions in the agreement entered into by our sponsor and management team. Our sponsor and each member of our management team have agreed not to transfer, assign or sell the founder shares for a period ending on the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination. The private placement units (other than those issued upon conversion of working capital loans) and the respective Class A ordinary shares underlying such units are not transferable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. The foregoing restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement or in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units or Class A ordinary shares, as applicable, were originally purchased; (f) by virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (g) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h) in the event of our liquidation prior to the completion of our initial business combination; or (i) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. For more information, also see “Principal Shareholders—Transfers of Founder Shares and Private Placement Units.” For more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares.”

SEC lock-up paragraph; source 2076438:2080252; SHA256 87ed8c98f057f0c4487e82a52ee6c5fbeed3bcd5d6ba920ed2cd8c0c350e086b ↗
the founder shares

Our letter agreement with our sponsor, officers and directors contain provisions relating to transfer restrictions of our founder shares and private placement warrants, indemnification of the trust account, waiver of redemption rights and participation in liquidating distributions from the trust account. The letter agreement may be amended without shareholder approval (although releasing the parties from the restriction not to transfer the founder shares for 180 days following the date of this prospectus will require the prior written consent of the underwriters). While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses to approve one or more amendments to the letter agreement. Any such amendments to the letter agreement would not require approval from our shareholders and may have an adverse effect on the value of an investment in our securities.

SEC lock-up paragraph; source 806691:807852; SHA256 bba8d10b503d05943cd7b766e3caae779b4ae4186705b6a062cf50bd2df87525 ↗
the private placement units

assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement units (other than those issued upon conversion of working capital loans) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Because each of our executive officers and director nominees will own ordinary shares or warrants directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.

SEC lock-up paragraph; source 1686996:1688453; SHA256 5a573f59fbc57f28b556cbc53aace339190a6b79a195e6b83cf4f7d765c928fa ↗
the private placement warrants

Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering; provided, however, that the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will not be exercisable more than five years from the commencement of sales in this offering in accordance with FINRA Rule 5110(g)(8). Further, the private placement warrants included in the private placement units that are deemed underwriters’ compensation pursuant to FINRA rules will be subject to a lock-up restriction, as required by FINRA Rule 5110(e)(1), and may not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of such securities by any person for a period of 180 days immediately following the date of commencement of sales of the offering, except as provided in FINRA Rule 5110(e)(2). The private placement warrants (including the Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination, unless approved by our public shareholders (except pursuant to limited exceptions as described under “Principal Shareholders—Transfers of Founder Shares and Private Placement Units”; for more information on the 180 day-transfer restrictions applicable to the securities deemed underwriters’ compensation pursuant to FINRA rules, please see below under “Underwriting (Conflicts of Interest)—Conflicts of Interest, QIU Fees, and Purchase of Private Placement Units and Founder Shares”), and they will not be redeemable by us so long as they are held by our sponsor or its permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis.

SEC lock-up paragraph; source 1837667:1840091; SHA256 8acb5d1bedac4dde8dcf37e1ec02d55b32afc26ad19e7510571f6a496161ca25 ↗
the private placement warrants

Except as described herein, our sponsor, officers and directors have agreed not to transfer, assign or sell their founder shares until the earlier of (i) the six month anniversary of the completion of our initial business combination and (ii) the date on which the closing price of our Class A ordinary shares exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination; provided that the restriction shall immediately terminate upon the date following the completion of our initial business combination in which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Our sponsor, officers and directors have also agreed not to transfer, assign or sell private placement units (including the Class A ordinary shares issuable upon exercise of the private placement warrants) until 30 days after the completion of our initial business combination, unless approved by our public shareholders. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor with respect to any founder shares. These transfer restrictions terminate upon the completion of a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. We refer to such transfer restrictions throughout this prospectus as the lock-up.

SEC lock-up paragraph; source 1941422:1943288; SHA256 b3ca2e7d20557f67f4f638e52368f5b860604f353389115c9c9773e6e24c18ac ↗
the private placement units

Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Any such payments will be made either (i) prior to our initial business combination using proceeds of this offering and the sale of the private placement units held outside the trust account or from loans made to us by our sponsor or an affiliate of our sponsor or certain of our officers and directors or (ii) in connection with or after the consummation of our initial business combination.

SEC lock-up paragraph; source 431997:433223; SHA256 f17717e16e180e32adae27d97fba86b88fe77f4649a82eec5122e33ca5bdb12c ↗
the private placement units

the formation promissory note and the grid promissory note to be used for, among other things, working capital, transaction expenses and other expenses related to this offering and our operations. To date, we have borrowed $25,000 and $78,898.08 under the formation promissory note and grid promissory note, respectively. For a more complete description of the terms of the promissory notes, see “Certain Relationships and Related Party Transactions.” If we are required to seek additional capital, we would need to borrow funds from our sponsor, its affiliates, members of our management team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor their affiliates is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or from funds released to us upon the completion of our initial business combination. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account. If we have not consummated our initial business combination within the required time period because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless. See “—If third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received by shareholders may be less than $10.00 per public share” and other risk factors herein.

SEC lock-up paragraph; source 609867:612380; SHA256 a896a7c63249e603a29953ce24fe2b572fbf8879fc109120a42e11cb99e847c4 ↗
the private placement units

In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. Otherwise, such loans may be repaid only out of funds held outside the trust account. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. Except as set forth above, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans. Prior to the completion of our initial business combination, we do not expect to seek loans from parties other than our sponsor, its affiliates or members of our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

SEC lock-up paragraph; source 995771:997489; SHA256 94371c8d080e0dc5b857161d7e414d2343a39552f437aea0000b8536c7fc2987 ↗
the private placement units

In addition, in order to finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our sponsor, its affiliates or our management team as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

SEC lock-up paragraph; source 1753442:1754994; SHA256 409e936bd12c8e0e816d2c4166684d599725098e81e61c266eb3e84cf23a3091 ↗
the private placement units

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into private placement units at a price of $10.00 per private placement unit at the option of the lender. Such private placement units would be identical to the private placement units sold in connection with this offering but will not be subject to a 30-day transfer restriction following our initial business combination.

SEC lock-up paragraph; source 1843028:1843804; SHA256 0951346a60d9107e1d62e2bad7bf2ed934cf426ee4a1ebfb083f424613e9ce49 ↗
private placement units

Our sponsor has committed, pursuant to a written agreement, to purchase an aggregate of 194,375 private placement units (or 200,000 private placement units if the over-allotment option is exercised in full) for a purchase price of $10.00 per unit in a private placement that will occur simultaneously with the closing of this offering. As such, our sponsor’s interest in this transaction is valued at between $7.60 and $9.70, depending on the number of private placement units purchased. Each private placement unit includes one private placement share and one-quarter of one warrant, each warrant to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. The private placement units (including the Class A ordinary shares and private placement warrants contained therein) may not, subject to certain limited exceptions, be transferred, assigned or sold by the holder until (i) with respect to 50% of the private placement units, for a period ending the earlier of (A) six months after the completion of our initial business combination and (B) subsequent to our initial business combination, if the closing price of our Class A ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period following our initial business combination and (ii) with respect to the other 50% of private placement units, until six months after the completion of our initial business combination, unless approved by our public shareholders

SEC lock-up paragraph; source 1310765:1312522; SHA256 eb6555437cfd8ff0b9a82dfc54656be526f9cdc296597458d1f38735a1e5464a ↗

Financial quality

Bars compare absolute amounts within each measure. Each measure has its own scale.

Net income / (loss)

$ · Annual values as reported
FY2024($3,800)
FY2025($6,221)
Financial quality
CalculationReported value
Cash and cash equivalents2025-12-31$19,238
Current assets2025-12-31$24,982
Current assets2024-12-31$6,203
Total assets2025-12-31$24,982
Total assets2024-12-31$6,203
Current liabilities2025-12-31$25,000
Total liabilities2025-12-31$25,000
General and administrative expensesFY2025$6,221
General and administrative expensesFY2024$3,800
Net income / (loss)FY2025($6,221)
Net income / (loss)FY2024($3,800)
Operating cash flowFY2025($5,762)
Cash and cash equivalents2026-06-30 · Unaudited$11,963
Current assets2026-06-30 · Unaudited$17,707
Total assets2026-06-30 · Unaudited$91,260
Current liabilities2026-06-30 · Unaudited$98,553
Total liabilities2026-06-30 · Unaudited$98,553
Total equity / (deficit)2026-06-30 · Unaudited($7,293)
Total equity / (deficit)2025-12-31($18)
General and administrative expenses6M ended 2026-06-30 · Unaudited$7,275
Net income / (loss)6M ended 2026-06-30 · Unaudited($7,275)
Operating cash flow6M ended 2026-06-30 · Unaudited($7,275)
Basis and evidence
Cash and cash equivalents
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current assets
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total current assets
December 31, 2024; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
TOTAL ASSETS
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
TOTAL ASSETS
December 31, 2024; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2024-12-31
Total current liabilities
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Total Liabilities
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Formation, general and administrative expenses
FY2025; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
Formation, general and administrative expenses
FY2024; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2024-12-31
Net loss
FY2025; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
Net loss
FY2024; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2024-12-31
Net cash used in operating activities
FY2025; issuer; currency symbol as printed ($); ISO currency not assigned; year ended 2025-12-31
Cash and cash equivalents
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total current assets
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
TOTAL ASSETS
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total current liabilities
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total Liabilities
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total Shareholder’s Deficit
June 30, 2026; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; as of 2026-06-30
Total Shareholder’s Deficit
December 31, 2025; issuer; currency symbol as printed ($); ISO currency not assigned; as of 2025-12-31
Formation, general and administrative expenses
6M ended 2026-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
Net loss
6M ended 2026-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
Net cash used in operating activities
6M ended 2026-06-30; issuer unaudited; currency symbol as printed ($); ISO currency not assigned; 6 months ended 2026-06-30
Financial quality and runway
Financial review

Financial quality and runway

The supplied excerpts identify June 30, 2026 as a financial reference date and disclose unaudited equity information, but do not provide sufficient numerical income, cash-flow, balance-sheet or complete capitalization data.

Cash and cash equivalents$19,238
Total current assets$24,982
Total current assets$6,203
EvidenceFinancial review 1

As of June 30, 2026, the excerpt states no Class A shares were issued or outstanding and 2,156,250 Class B shares were issued and outstanding.

EvidenceFinancial review 2

The sponsor formation note had $25,000 outstanding and the grid note had $78,898.08 outstanding as of the prospectus date.

LATEST COMPARISON

MATERIAL CHANGES

The latest material signals and their investor impact are shown below.

Open 424B4 ↗
CHANGE 01Offering became effective prospectus / Nasdaq status

Why it mattersThe current filing is Form 424B4 and states that the units have been approved for Nasdaq listing; the prior excerpt stated an intention to apply.

Evidence · Cover and opening disclosure; Ownership and control — later disclosure
CHANGE 02Current closing and delivery timetable

Why it mattersThe current evidence states expected delivery on or about August 28, 2026 and identifies the prospectus date as August 26, 2026; the prior excerpt does not provide this same final timetable.

Evidence · Offering — later disclosure
IPO177 explains the investment effect; the SEC source remains the authoritative record. Page-level locators are shown only when extracted and verified.

Loading filing history…

Risk 2

Large redemptions may prevent completion of the most desirable business combination or an optimized capital structure.

Risk 3

The sponsor and management may have fiduciary or contractual obligations to other entities and may face conflicts in allocating opportunities.

Document424B40001104659-26-102498
Filed2026-08-27SEC EDGAR
Research updated2026-09-07Analysed
Source-bound table inputs51SEC EDGAR
Open filing ↗